Eligible AACR 2019 Annual Meeting Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 9 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 9 presentations: 1 to 25 of 215
Introduction
Folakemi T Odedina
Univ. of Florida Health Cancer Center, Orlando, FL, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
The Surveillance, Epidemiology, and End Results (SEER) program
Kathy Cronin
NIH, Bethesda, MD, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Integrating spatial science with SEER data
Trang M VoPham
Harvard School of Public Health, Boston, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Use of prospective approaches to characterize cancer registry data
Folakemi T Odedina
Univ. of Florida Health Cancer Center, Orlando, FL, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Discovery of BLU-667 for RET driven cancers
Jason Brubaker
Blueprint Medicines, Cambridge, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Discovery and development of USP7 inhibitors
Tim Harrison
Almac Discovery, Belfast, Ireland
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Identification and optimization of chemical series that lead to discovery of erdafitinib: A potent pan-fibroblast growth factor receptor (FGFR) inhibitor
Patrick Angibaud
Janssen R & D, Val-de-Reuil, France
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Development of potent and selective CD73 inhibitors: Discovery and characterization of AB680
Jenna Jeffrey
Arcus Biosciences, Inc., Hayward, CA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
How to develop trial objectives: Translation of science from bench to bedside to bench
Patricia M LoRusso
Yale Cancer Center, New Haven, CT, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Modernizing eligibility criteria for oncology clinical trials
Tatiana Prowell
U.S. Food and Drug Administration and Johns Hopkins Kimmel Cancer Center, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Biostatistical principals of clinical trial design
Mithat Gonen
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Designing meaningful and impactful clinical trials
Jyoti D Patel
Univ. of Chicago Medical Ctr., Chicago, IL, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Systems Immunology and tumor microenvironment: Novel perspectives
Jérôme Galon
INSERM UMRS1138 - Cordeliers Research Ctr., Paris, France
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Blocking the heterotypic interactions of tumor and TME to control late stage cancer
Dihua Yu
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Exploring the metastatic niche
Ilaria Malanchi
The Francis Crick Institute, London, United Kingdom
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Mechanisms underlying polyclonal metastases
Kornelia Polyak
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Intended clinical application drives your study design: Principles and operational considerations
Ziding Feng
Fred Hutchinson Cancer Research Ctr., Seattle, WA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Evaluating biomarkers for prognostic enrichment of clinical trials
Kathleen Kerr
University of Washington, Seattle, WA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Deriving early detection biomarker performance goals by setting a minimum benefit-to-harm ratio
Steven J Skates
Massachusetts General Hospital, Boston, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Machine learning in imaging: Seeing the invisible
Christos Davatzikos
Center for Biomedical Image Computing and Analytics, Philadelphia, PA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Machine learning in imaging: Seeing the invisible
Saima Rathore
University of Pennsylvania, Philadelphia, PA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Deep learning: Promises and challenges
Jayashree Kalpathy-Cramer
Harvard Medical School/MGH, Charlestown, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Deep learning for reading mammograms: state-of-the-art and clinical implementation
Regina Barzilay
MIT, Cambridge, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
AI tools for computational pathology
Lee Cooper
Emory University, Atlanta, GA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Regulation of ROS and cancer progression
Karen H Vousden
The Francis Crick Institute, London, United Kingdom
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
<< first | < prev page: of 9 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 9 presentations: 1 to 25 of 215